270520 — APT Neuroscience Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩183bn
- KR₩99bn
- KR₩18bn
Annual cashflow statement for APT Neuroscience, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3,606 | -930 | -3,248 | -5,003 | -19,167 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 4,569 | 1,147 | -740 | -199 | 7,614 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 385 | 3,901 | 5,024 | 11 | 155 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,455 | 4,234 | 1,152 | -4,682 | -10,234 |
| Capital Expenditures | -85.1 | -23.7 | -2,212 | -4,179 | -511 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 4,257 | 352 | -4,802 | -56,820 | 27,429 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 4,172 | 328 | -7,014 | -60,999 | 26,919 |
| Financing Cash Flow Items | 7.22 | -18.2 | 27.8 | -28 | -10.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3,483 | -5.23 | 32,494 | 46,151 | 124,754 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9,107 | 4,561 | 26,636 | -19,507 | 143,080 |